selenocyanic acid (selenocyanate)

Also Known As:
selenocyanate; selenocyanate potassium
Networked: 9 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results


1. Amin, Shantu: 2 articles (10/2011 - 07/2006)
2. Sinha, Raghu: 2 articles (07/2006 - 07/2004)
3. El-Bayoumy, Karam: 2 articles (07/2006 - 07/2004)
4. Tagaram, Hephzibah Rani S: 1 article (10/2011)
5. Prakasha Gowda, A S: 1 article (10/2011)
6. Carroll, Kevin F Staveley-O': 1 article (10/2011)
7. Sharma, Arun K: 1 article (10/2011)
8. Krishnegowda, Gowdahalli: 1 article (10/2011)
9. Irby, Rosalyn B: 1 article (10/2011)
10. Scozzafava, Andrea: 1 article (03/2010)

Related Diseases

1. Neoplasms (Cancer)
11/01/2005 - "The compound 2-(2-selenocyanic acid ethyl ester)-1H-benz[de] isoquinoline-1,3-(2H)-dione (SEBID), a ubiquitous, bioactive naphthalimide derivative is expected to possess an anticancer, anti-tumor and other important therapeutic activities of significant potency with low systematic toxicity. "
04/01/2000 - "We have consistently shown that 1, 4-phenylene bis(methylene) selenocyanate (p-XSC) is a highly effective cancer chemopreventive agent against the development of chemically induced cancers in several laboratory animal species. "
07/13/2004 - "We have demonstrated that 1,4-phenylenebis (methylene) selenocyanate (p-XSC) and its putative metabolite glutathione conjugate (p-XSeSG) are highly promising agents in the chemoprevention of mammary carcinogenesis in the 7,12-dimethylbenz[a]anthracene (DMBA)-rat mammary tumor model system. "
11/01/1994 - "As a part of a program aimed to develop less toxic and more effective chemopreventive organoselenium compounds than inorganic selenium, we have evaluated benzyl selenocyanate (BSC) and its o-, m-, p-nitro and -methoxy isomers, o-, m-, and p-isomers of phenylenebis(methylene)selenocyanate (XSC), dibenzyl diselenide (DDS), and 2,2'-diselenobis[((N,N-dimethylamino)methyl)- benzene]bis(hydrochloride salt) (DSBDB) for their potential colon tumor inhibitory properties using azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF), a preneoplastic lesion, in male F344 rats prior to preclinical efficacy study. "
03/01/2010 - "An inhibition study of the transmembrane carbonic anhydrase (CA, EC isoforms IX, XII (tumor-associated), and XIV with anions such as stannate(IV), selenate(VI), tellurate(VI), perosmate(VIII), persulfate, pyrophosphate(V), pyrovanadate(V), tetraborate, persulfate, perrhenate(VII), perrutenate(VII), selenocyanate, iminodisulfonate, fluorosulfate, and trithiocarbonate is reported. "
2. Aberrant Crypt Foci
3. Prostatic Neoplasms (Prostate Cancer)
4. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Protein Isoforms (Isoforms)
2. Organoselenium Compounds
3. Selenium
4. Carbonic Anhydrases (Carbonic Anhydrase)
5. Benzene (Benzole)
6. Azoxymethane
7. Anions
8. dibenzyl diselenide
9. selenic acid (selenate)
10. benzyl selenocyanate

Related Therapies and Procedures

1. Chemoprevention